Technical Analysis for CLVLY - Clinuvel Pharm ADR

Grade Last Price % Change Price Change
grade B 16.01 0.88% 0.1400
CLVLY closed up 0.88 percent on Wednesday, June 3, 2020, on 1.6 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical CLVLY trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 0.88%
Narrow Range Bar Range Contraction 0.88%
Inside Day Range Contraction 0.88%
Overbought Stochastic Strength 0.88%
Expansion Breakout Bullish Swing Setup 0.82%
Pocket Pivot Bullish Swing Setup 0.82%
Gapped Up Strength 0.82%
Older signals for CLVLY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Clinuvel Pharmaceuticals Limited is a biopharmaceutical company. The Company is focused on developing drugs for the treatment of a range of severe skin disorders. Its lead compound, SCENESSE (afamelanotide 16 milligrams), prevents phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company focuses at preventing the symptoms of skin diseases related to the exposure to harmful ultra violet (UV) radiation and at repigmentation of the skin due to a number of depigmentation disorders. SCENESSE has completed Phase II and III trials in the United States and Europe, and has been granted marketing authorization by the European Commission for adults with EPP. It has operations in Europe, the United States and Singapore. SCENESSE acts by increasing the levels of melanin in the skin and shields against UV radiation (UVR) and sunlight. SCENESSE is delivered via a subcutaneous dissolving implant.
Branches Of Biology Biopharmaceutical United States Organ Systems Radiation Burns Ultraviolet Skin Diseases Electrodynamics Peptides Severe Skin Disorders Treatment Of A Range Of Severe Skin Disorders

Is CLVLY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.8
52 Week Low 7.4
Average Volume 9,978
200-Day Moving Average 16.9146
50-Day Moving Average 13.5989
20-Day Moving Average 14.9911
10-Day Moving Average 15.3778
Average True Range 0.4864
ADX 17.22
+DI 43.6100
-DI 25.9727
Chandelier Exit (Long, 3 ATRs ) 14.5998
Chandelier Exit (Short, 3 ATRs ) 14.9342
Upper Bollinger Band 16.2495
Lower Bollinger Band 13.7327
Percent B (%b) 0.9
BandWidth 16.7886
MACD Line 0.5865
MACD Signal Line 0.5295
MACD Histogram 0.057
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.2935
Resistance 3 (R3) 16.2783 16.1687 16.2463
Resistance 2 (R2) 16.1687 16.0965 16.1763 16.2305
Resistance 1 (R1) 16.0893 16.0519 16.1290 16.1045 16.2147
Pivot Point 15.9797 15.9797 15.9995 15.9873 15.9797
Support 1 (S1) 15.9003 15.9075 15.9400 15.9155 15.8053
Support 2 (S2) 15.7907 15.8629 15.7983 15.7895
Support 3 (S3) 15.7113 15.7907 15.7738
Support 4 (S4) 15.7265